~34 spots leftby Aug 2025

Digital Health Tool for Physical Activity

(YourMove Trial)

Recruiting in Palo Alto (17 mi)
EH
DR
Overseen byDaniel Rivera, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of California, San Diego
No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to determine the efficacy of a new digital health tool that uses a phone and smartwatch to encourage physical activity and increase weekly amounts of Moderate to Vigorous Physical Activity (MVPA) over 12 months among adults compared to a digital health intervention that mimics a standard of care corporate wellness program.

Research Team

EH

Eric Hekler, PhD

Principal Investigator

University of California, San Diego

DR

Daniel Rivera, PhD

Principal Investigator

Arizona State University

Eligibility Criteria

This trial is for adults aged 25-80 who are healthy enough to be active, can use a smartwatch and app, and have a BMI of 18-40. They must commit to a year-long program and attend three check-ups. It's not for those in other activity programs, with conditions affecting participation or with devices like pacemakers.

Inclusion Criteria

Intend to be available for a 12-month intervention
Willing and able to use a smartphone and text messaging
Willing and able to use the wearable and corresponding app
See 5 more

Exclusion Criteria

Those with a mechanical medical implant, such as a pacemaker
Psychiatric or medical conditions that prohibit compliance with the study protocol
Enrolled in or planning to enroll in a physical activity program during the study period

Treatment Details

Interventions

  • COT-Based Intervention (Behavioral Intervention)
Trial OverviewThe study tests a new mobile health tool that pairs with your phone and watch to boost physical activity over the course of a year. It will be compared against standard digital wellness programs to see if it helps people do more moderate-to-vigorous exercise.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: COT-Based InterventionExperimental Treatment1 Intervention
The COT-based intervention will include the following to improve both steps/day (move more), and improving minutes/week of MVPA (exercise): adaptive daily steps/day goal-setting plus feedback; positive reinforcement (i.e., points, which translate to gift cards), self-monitoring of both steps/day and min/week MVPA; education about MVPA sent via text message in both conditions; planning support for scheduling bouts of MVPA via SMS in both conditions; and motivational messages sent via SMS in both conditions, and the use of a self-experimentation tool (REFLECT), developed based on prior successful pilot efforts, focused on fostering effective self-regulatory capacities of individuals.
Group II: ControlActive Control1 Intervention
The non-COT approach was designed to be an equivalent to emerging standard of care options for digital health worksite wellness programs to increase PA (control) for a 12-month study period. Participants assigned to the non-COT-based (control) group will receive the latest Fitbit Versa smartwatch and will download the Fitbit smartphone app. Unlike the intervention group, the daily step goal and the accompanying number of points will be static (10,000 steps/day; 150 points/day, respectively). The goal will be delivered to participants via the standard Fitbit app features and points will be communicated via email. Participants will also receive a weekly PA goal (150 minutes of MVPA/per week) and the same accompanying motivational and informative texts that the intervention group receives. Control participants will not complete the physical activity and exercise reflection and planning exercise (Reflect).

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1,215
Recruited
1,593,000+
Dr. Christopher Longhurst profile image

Dr. Christopher Longhurst

University of California, San Diego

Chief Medical Officer since 2021

MD and MS in Medical Informatics from UC Davis

Patty Maysent profile image

Patty Maysent

University of California, San Diego

Chief Executive Officer since 2016

MBA from Stanford University

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+
Dr. Douglas R. Lowy profile image

Dr. Douglas R. Lowy

National Cancer Institute (NCI)

Chief Executive Officer since 2023

MD from New York University School of Medicine

Dr. Monica Bertagnolli profile image

Dr. Monica Bertagnolli

National Cancer Institute (NCI)

Chief Medical Officer since 2022

MD from Harvard Medical School

Small Steps Labs, LLC

Collaborator

Trials
3
Recruited
1,100+

Arizona State University

Collaborator

Trials
311
Recruited
109,000+
Mark McKenna profile image

Mark McKenna

Arizona State University

Chief Executive Officer

Bachelor’s degree in marketing from Arizona State University, MBA from Azusa Pacific University

Cedric O’Gorman profile image

Cedric O’Gorman

Arizona State University

Chief Medical Officer since 2023

MD from Harvard Medical School

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

Marschall S. Runge

University of Michigan

Chief Executive Officer since 2015

MD, PhD

Karen McConnell profile image

Karen McConnell

University of Michigan

Chief Medical Officer since 2020

MD